LABORATORIOS FARMACEUTICOS ROVI SA
LABORATORIOS FARMACEUTICOS ROVI S.../ ES0157261019 /
LABFF
|
01/07/2024 21:24:23
|
Chg.
-
|
Volume |
Bid- |
Demandez à- |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
90.6100USD
|
-
|
100
Chiffrre d'affaires: 9,061 |
-Bid taille: - |
-Ask la taille: - |
3.55 Mrd.USD |
- |
- |
Description de l'entreprise
Laboratorios Farmaceuticos Rovi, S.A., headquartered in Madrid, Spain, develops, manufactures, and markets pharmaceutical products globally. Key products include Enoxaparin Rovi, Hibor, and Iomeron. Rovi also offers contract manufacturing services for prefilled syringes, vials, and more. Founded in 1946, it operates across cardiology, women's health, pain management, and other therapeutic areas.
Conseil d'administration & Conseil de surveillance
| PDG |
| Juan López-Belmonte Encina |
| Conseil d'administration |
| - |
| Conseil de surveillance |
| Iván López-Belmonte Encina, Fátima Báñez García, Marina del Corral Téllez, Marcos Peña Pinto, Teresa Corzo Santamaría, Gabriel Núñez Fernández, Ignacio Zarzalejos Toledano, Juan López-Belmonte Encina, Javier López-Belmonte Encina |
Données de l'entreprise
| Nom: |
Laboratorios Farmaceuticos Rovi, S.A. |
| Adresse: |
Calle José Isbert, 2,28223 Pozuelo de Alarcón (Madrid) |
| Téléphone: |
+34-91-021-3000 |
| Fax: |
- |
| Courriel: |
rovi@rovi.es
|
| Internet: |
https://www.rovi.es/ |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
35.68% |
| IPO date: |
- |
Relations avec les investisseurs
| Nom: |
- |
| Téléphone IR: |
+34-91-244-4422 |
| IR-Fax: |
- |
| E-mail IR: |
ir@rovi.es
|
